Jason Hannon - 10 Jun 2026 Form 4 Insider Report for Orthofix Medical Inc. (OFIX)

Reporting relationship: Director
Issuer ticker: OFIX
Reported as of: 10 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 12 Jun 2026, 18:29:42 UTC
Prior SEC filing: 23 Jun 2025
Source filing: View source filing
Reporting owner signature: /s/ J. Andres Cedron, attorney-in-fact

Key filing fact

Jason Hannon filed Form 4 for Orthofix Medical Inc. (OFIX) on 12 Jun 2026.

Key facts

This page summarizes Jason Hannon's Form 4 filing for Orthofix Medical Inc. (OFIX).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 12 Jun 2026, 18:29.

Change

Previous filing in this sequence was filed on 23 Jun 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001330401 Primary reporting owner

Hannon Jason

Relationship: Director
Address: 3451 PLANO PARKWAY, LEWISVILLE
Signature: /s/ J. Andres Cedron, attorney-in-fact
Signature date: 12 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

OFIX transaction

Common Stock

Award

Transaction value
Shares: +14,965
Change %: +21%
Price: $0.000000^*
Shares after: 87,662
Date: 10 Jun 2026
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents an award of deferred stock units that vest in full on the first anniversary of the grant date, subject to the reporting person's service through such date. Each deferred stock unit represents a contingent right to receive one share of common stock of the issuer. Vested deferred stock units will settle and convert into common stock within 45 days of the reporting person's termination of service with the issuer.

Footnote F2

Includes 63,631 previously reported deferred stock units and an aggregate of 2,103 shares acquired under Orthofix's Stock Purchase Plan ("Orthofix's SPP") on 10/31/2025 and 4/30/2026. Orthofix's SPP is a "Stock Purchase Plan" as defined in Rule 16b-3(b)(5), and share acquisitions under the plan are exempt from Section 16(b).